People channel feed

Re­gen­eron's Schleifer, Yan­copou­los set their com­pa­ny's am­bi­tions sky high with $1.4B on the ta­ble in per­for­mance awards

5 years ago

Mace Rothen­berg starts the year by step­ping out of his top job in Pfiz­er R&D — as Stan­ford’s Ai­da Habtezion steps in

5 years ago

Lynn Seely hits the ex­it as My­ovant grad­u­ates to com­mer­cial space — hand­ing the reins to Am­gen vet

5 years ago

Trump par­dons Chris Collins, for­mer con­gress­man im­pris­oned for biotech in­sid­er trad­ing scan­dal

5 years ago

Pe­ter Thiel joins fund­ing round for pep­tide drug play­er in lat­est swing at emerg­ing biotech mar­ket

5 years ago
Financing

For­mer J&J VP sues phar­ma gi­ant for discim­i­na­tion and ha­rass­ment, ac­cus­es top ex­ecs — in­clud­ing Alex Gorsky — of re­tal­i­at­ing against her

5 years ago

Sam­sung Bi­o­log­ics pro­motes new CEO from with­in to head next phase of rapid man­u­fac­tur­ing ex­pan­sion

5 years ago
Outsourcing

Al­ny­lam trail­blaz­er Bar­ry Greene jumps to the helm of a strug­gling Sage Ther­a­peu­tics. Can he de­liv­er an­oth­er come­back?

5 years ago

Bob Nelsen ex­its board and pres­i­dent steps down at Uni­ty as fall­out from the an­ti-ag­ing biotech's PhII miss con­tin­ues

5 years ago
Pharma

Sarep­ta shakes up C-suite as they pre­pare to test FDA on Duchenne again

5 years ago

Mass­Bio head Cough­lin set to step down af­ter over­see­ing mas­sive bio­phar­ma ex­pan­sion in the state dur­ing 13-year tenure

5 years ago
R&D

Long­time In­ter­cept CEO Mark Pruzan­s­ki de­parts as ail­ing NASH com­pa­ny tries to find its fu­ture

5 years ago

New York law­suit again ac­cus­es Mar­tin Shkre­li of ma­nip­u­la­tion from be­hind bars

5 years ago
Pharma

Spe­cial re­port: Twen­ty ex­tra­or­di­nary women blaz­ing trails in bio­phar­ma R&D — Covid-19 and be­yond

5 years ago
Special

Af­ter build­ing pipelines from Glax­o­SmithK­line to Flag­ship, Paul Pe­ter Tak takes the helm at an un­der-the-radar on­colyt­ic virus play­er

5 years ago

Carl Hansen is just about ready to grab the key to the ex­clu­sive Cov­il­lion­aire club

5 years ago
Bioregnum
Opinion

Af­ter tak­ing on phar­ma M&A, 'pay-for-de­lay' and Gilead­'s remde­sivir pric­ing, Cal­i­for­nia AG tapped to lead HHS — re­ports

5 years ago

BioN­Tech chief Ugur Sahin gains star sta­tus in the ex­clu­sive Cov­il­lion­aire club

5 years ago
R&D

Lau­ra Shawver is about to join a line­up of biotech CEOs en­joy­ing overnight for­tunes, cour­tesy of the biotech IPO boom

5 years ago
Financing

A top can­cer R&D ex­ec at Genen­tech joins the ex­o­dus, jump­ing to a mar­quee Chi­na biotech as the new on­col­o­gy chief, deal­mak­er

5 years ago

Not so fast, Mr Pres­i­dent: Trump's plan for low­er­ing pre­scrip­tion drug prices hits a road­block, as Cana­da bans bulk drug ex­ports

5 years ago
Pharma

Plot thick­ens around Leg­end Biotech, Gen­Script with founder Frank Zhang's ar­rest

5 years ago
China

Vivek Ra­maswamy’s Meta­vant hits a brick wall, aban­don­ing a lead pro­gram for di­a­betes. And there’s noth­ing vis­i­ble left to see here

5 years ago
R&D

For­mer MiMedx CEO and COO are con­vict­ed on fraud, con­spir­a­cy charges

5 years ago
First page Previous page 63646566676869 Next page Last page
A service from the Financial Times